You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

SULFAMETHOXAZOLE AND TRIMETHOPRIM Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Sulfamethoxazole And Trimethoprim, and when can generic versions of Sulfamethoxazole And Trimethoprim launch?

Sulfamethoxazole And Trimethoprim is a drug marketed by Abraxis Pharm, Bedford, Hikma, Hospira, Mylan Labs Ltd, Somerset, Teva Pharms Usa, Watson Labs, Ani Pharms, Aurobindo Pharma, Chartwell Molecular, Lupin Ltd, Novitium Pharma, Prasco, Teva, Amneal Pharms Ny, Chartwell Molecules, Fosun Pharma, Glenmark Pharms Ltd, Heather, Interpharm, Martec Usa Llc, Mutual Pharm, Pliva, Roxane, Sun Pharm Industries, Usl Pharma, Vista Pharms, Able, and Heritage Pharma Avet. and is included in forty-seven NDAs.

The generic ingredient in SULFAMETHOXAZOLE AND TRIMETHOPRIM is phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim. There are eight drug master file entries for this compound. Additional details are available on the phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for SULFAMETHOXAZOLE AND TRIMETHOPRIM?
What are the global sales for SULFAMETHOXAZOLE AND TRIMETHOPRIM?
What is Average Wholesale Price for SULFAMETHOXAZOLE AND TRIMETHOPRIM?

Summary for SULFAMETHOXAZOLE AND TRIMETHOPRIM

US Patents:	0
Applicants:	30
NDAs:	47
Finished Product Suppliers / Packagers:	46
Raw Ingredient (Bulk) Api Vendors:	24
Clinical Trials:	151
Patent Applications:	2,533
What excipients (inactive ingredients) are in SULFAMETHOXAZOLE AND TRIMETHOPRIM?	SULFAMETHOXAZOLE AND TRIMETHOPRIM excipients list
DailyMed Link:	SULFAMETHOXAZOLE AND TRIMETHOPRIM at DailyMed

Drug patent expirations by year for SULFAMETHOXAZOLE AND TRIMETHOPRIM

Recent Clinical Trials for SULFAMETHOXAZOLE AND TRIMETHOPRIM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cairo University	Phase 4
Johns Hopkins University	Early Phase 1
Chang Gung Memorial Hospital	Phase 1/Phase 2

See all SULFAMETHOXAZOLE AND TRIMETHOPRIM clinical trials

Pharmacology for SULFAMETHOXAZOLE AND TRIMETHOPRIM

Drug Class	Dihydrofolate Reductase Inhibitor Antibacterial Sulfonamide Antimicrobial
Mechanism of Action	Cytochrome P450 2C8 Inhibitors Cytochrome P450 2C9 Inhibitors Dihydrofolate Reductase Inhibitors Organic Cation Transporter 2 Inhibitors

US Patents and Regulatory Information for SULFAMETHOXAZOLE AND TRIMETHOPRIM

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	TABLET;ORAL	018242-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Interpharm	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	TABLET;ORAL	071299-001	Oct 27, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	TABLET;ORAL	070000-001	Nov 7, 1984		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Vista Pharms	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	TABLET;ORAL	076817-001	Oct 7, 2005	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Able	SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE	phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim	TABLET;ORAL	021105-001	Jun 26, 2001		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.